- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04792177
Internet-based Emotion Regulation Intervention for Sexual Health (SHER2)
November 11, 2022 updated by: University of Luxembourg
SHER 2: Internet-delivered Emotion Regulation Skills Training for Sexual Health: a Randomized Controlled Trial
Introduction: Emotion regulation difficulties have been associated with mental disorders and sexual dysfunctions.
Traditional face-to-face transdiagnostic emotion regulation interventions have shown positive results for emotional and personality disorders.
Only recently have the effects of these interventions on sexual health started to be investigated.
Internet-delivered psychological interventions have several advantages over face-to-face interventions, such as cost-effectiveness, accessibility and suitability for people who experience shame because of their stigmatized problematic behaviors and those who avoid seeking help.
The aims of the SHER 2 study are: a) determine the efficacy of an Internet-based emotion regulation intervention for sexual health and sexual satisfaction, and; b) explore the effects of the intervention on (1) emotion regulation skills; (2) mental health; (3) sexual self-perception.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
62
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Esch-sur-Alzette, Luxembourg, L-4365
- University of Luxembourg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- between 18 and 65 years of age,
- fluent in Brazilian Portuguese,
- self-reported sexual problems, assessed in men by a score of < 21 on the International Index Erectile Function (IIEF) and in women by a score of < 26 on the Female Sexual Function Index (FSFI),
- in a stable relationship for at least the preceding 3 months.
Exclusion Criteria:
- medical conditions that can interfere with the outcomes of the intervention, e.g., diabetes, cancer, cardiovascular problems,
- ongoing psychotherapy.
- no sexual activity in the previous 4 weeks.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
Emotion regulation skills training group
|
The intervention will involve an online emotion-regulation skills training for individuals with sexual problems.
It will last for 8 weeks, encompassing psycho-educational and emotion-regulation skills components.
Every week participants will gain access to a different intervention module of the training, containing videos, presentation slides, written support material and a recommendation of activities to be completed until the following week of training.
Participants are expected to dedicate 30 minutes to one hour per week to complete each module.
|
No Intervention: waitlist control group
The control group will not receive any intervention during the trial but will be offered the same treatment at the end of the six-months follow-up assessment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Female Sexual Function Index (FSFI) at 6 months
Time Frame: baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up)
|
this is a 19-item questionnaire for the assessment of sexual functioning in women in domains of sexual functioning (e.g., sexual arousal, orgasm, satisfaction, pain).
Answers are provided using a 5-point Likert scale.
|
baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up)
|
Change in International Index of Erectile Function (IIEF)at 6 months
Time Frame: baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up)
|
The IIEF is 15-item, self-administered questionnaire for assessing sexual functioning in men.
Answers are given on a 6-point Likert scale.
The IIEF encompasses five different domains of sexual functioning: erectile function, orgasm function, sexual desire, intercourse satisfaction and overall satisfaction.
|
baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up)
|
Change in Sexual Quotient (QS) at 6 months
Time Frame: baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up)
|
The QS is a brief and comprehensive tool composed of 10-questions, which are answered on a scale from 0 (never) to 5 (always).
It addresses general sexual function, and stages of the sexual response cycle (desire, arousal, orgasm) and sexual satisfaction.
|
baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sexual Modes Questionnaire (SMQ) - Automatic Thoughts subscale
Time Frame: baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up)
|
This self-report scale consists of 30 items in the male version, and 33 items in the female version.
Respondents are asked to rate the frequency (from 1 [never] to 5 [always]) with which they have experienced specific automatic thoughts during sexual activity.
|
baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up)
|
Sexual Self-Schema Scale (SSSS).
Time Frame: baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up)
|
consists of 30 items assessing respondents' perception of themselves as a sexual person compared to others of the same gender and age.
Answers are provided using a 5- point Likert scale ranging from 1 (not at all descriptive of me) to 5 (very much descriptive of me).
|
baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up)
|
Patient Health Questionnaire-9 (PHQ-9)
Time Frame: baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up)
|
A 9-item self-report measure used to assess symptoms of depression.
|
baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up)
|
General Anxiety Disorder - 7 (GAD-7)
Time Frame: baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up)
|
A 7-item self-report measure used to assess symptoms of anxiety.
|
baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up)
|
the Difficulties in Emotion Regulation Scale (DERS)
Time Frame: baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up)
|
The DERS assesses several facets of emotion regulation, including difficulties relevant to an individual's (a) acceptance of emotional responses, (b) ability to engage in goal-directed behaviour under distress, (c) ability to control impulsive behaviours when distressed, (d) access to emotion regulation strategies, and (e) emotional clarity.
Participants rate their degree of agreement with each statement on a scale from 1 (almost never; 0 to 10 percent) to 5 (almost always; 91 to 100 percent).
|
baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Claus Vögele, Prof. Dr, Head of Department Department of Behavioural and Cognitive Sciences
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 5, 2021
Primary Completion (Actual)
June 30, 2022
Study Completion (Actual)
July 30, 2022
Study Registration Dates
First Submitted
January 29, 2021
First Submitted That Met QC Criteria
March 8, 2021
First Posted (Actual)
March 10, 2021
Study Record Updates
Last Update Posted (Actual)
November 14, 2022
Last Update Submitted That Met QC Criteria
November 11, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SHER 20-029
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sexual Dysfunction
-
Istanbul University - Cerrahpasa (IUC)CompletedSexual Dysfunction | Pregnancy Related | Postpartum Sexual DysfunctionTurkey
-
BayerCompletedSexual Dysfunction | Male Erectile DysfunctionBelgium, Italy, France, Germany, Spain, Netherlands, South Africa
-
Cairo UniversityCompleted
-
Alza Corporation, DE, USACompletedSexual Dysfunction | Erectile Dysfunction | Ejaculation
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSexual Dysfunction | Erectile DysfunctionFrance, Poland, United States, Belgium, Mexico, Malaysia, Canada, Taiwan, Korea, Republic of, Russian Federation, Argentina, Australia, United Kingdom
-
Royal Holloway UniversityNational Health Service, United KingdomCompletedSexual Dysfunction | Sexual Assault | Sex DisorderUnited Kingdom
-
University of UtahAcerus Pharmaceuticals CorporationWithdrawnSexual Dysfunction | Erectile DysfunctionUnited States
-
Man Clinic for Andrology, Male Infertility and...UnknownSexual Dysfunction | Erectile Dysfunction | Premature EjaculationEgypt
-
Assiut UniversityNot yet recruitingSexual Dysfunction
Clinical Trials on Emotion regulation skills training
-
Icahn School of Medicine at Mount SinaiNational Institute on Disability, Independent Living, and Rehabilitation...CompletedTraumatic Brain Injury | Executive Dysfunction | Emotion Dysregulation | Emotion DysfunctionUnited States
-
Region ÖstergötlandCompletedEmotions | Eating Disorders | Skill, CopingSweden
-
Douglas Mental Health University InstituteRecruitingTrauma | Psychosis | Emotion RegulationCanada
-
Region ÖstergötlandRecruitingBehavioral Symptoms | Emotional InstabilitySweden
-
University of Massachusetts, AmherstNational Institute of Mental Health (NIMH); University of ToledoCompletedBorderline Personality DisorderUnited States
-
Fundació Institut de Recerca de l'Hospital de la...CompletedMajor Depressive Disorder
-
Teachers College, Columbia UniversityUniversity of MichiganActive, not recruitingDepression | Anxiety | Distress, Emotional | Emotional DysfunctionUnited States
-
Dartmouth-Hitchcock Medical CenterWithdrawn
-
Bryan DennyNational Institute on Aging (NIA)RecruitingStress | Emotions | Emotion Regulation | Psychological | Caregivers | PsychophysiologyUnited States
-
Icahn School of Medicine at Mount SinaiCompletedBorderline Personality Disorders | Avoidant Personality DisordersUnited States